Report Overview

The EU Infectious Disease Diagnostics market size stood at round USD $4.38 billion in 2019 and is projected to reach USD $6.24 billion by 2028, exhibiting a CAGR of xx% during the forecast period

Infectious disease diagnostics refers to the testing and diagnostic of presence of any infectious organisms in the body. These tests are widely performed with the help of assays, kits, instruments and reagents. The tests whose kits are commonly available for sexually transmitted diseases and bacterial infections. Infectious disease tests have a surging demand due to rising infectious disease among people and are usually done in the hospital, clinical laboratories, reference laboratories, physician offices and research institutes



Market Drivers

The rise in infectious diseases across Europe has led to a growing need for early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is a vital part of the clinical diagnostics market and is rapidly evolving into the preferred testing mode as rapid infection diagnosis results in lower antibiotic intake, fewer lab tests for patients, and reduced treatment cost. This is cost-effective not just for patients but also for hospitals. There has been a rise in the availability of funding and investment for the research in infectious disease which is fueling the market growth